{"url_path":"/sec/inab/8-k/2026-06-01/item-1-02","section_key":"item-1-02","section_title":"Item 1.02 Termination of a Material Definitive Agreement.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-01","source_url":"https://www.sec.gov/Archives/edgar/data/1740279/0001193125-26-249684-index.html","accession_number":"0001193125-26-249684","cik":"0001740279","ticker":"INAB","issuer_name":"IN8BIO, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1740279/0001193125-26-249684-index.html","primary_entity_key":"0001740279","primary_entity_name":"IN8BIO, INC."},"word_count":258,"has_tables":true,"body_markdown":"Item 1.02\n\nTermination of a Material Definitive Agreement.\n\nAs previously disclosed, on November 10, 2022 the Company entered into a Controlled Equity OfferingSM Sales Agreement with Cantor Fitzgerald & Co. (“Cantor”) as sales agent (the “Cantor Sales Agreement”), pursuant to which the Company was permitted to issue and sell, from time to time through Cantor, shares of the Company’s Common Stock.\n\nOn May 29, 2026, the Company and Cantor mutually agreed to terminate the Cantor Sales Agreement and the offering of shares contemplated thereby, effective at the close of business on May 29, 2026, pursuant to Sections 12(b) and 12(c) of the Cantor Sales Agreement. The Company and Cantor each waived the other party’s requirement in Sections 12(b) and 12(c) of the Cantor Sales Agreement to provide five (5) days’ written notice to terminate the Cantor Sales Agreement. The Company is not subject to any termination penalties related to the termination of the Cantor Sales Agreement.\n\nFollowing the termination of the Cantor Sales Agreement, the Company may not issue or sell any additional shares of its common stock under the Cantor Sales Agreement or the related prospectus.\n\nThe foregoing description of the Cantor Sales Agreement is not complete and is qualified in its entirety by reference to the full text of the Cantor Sales Agreement, a copy of which was filed as Exhibit 1.2 to the Company’s shelf registration statement on Form S-3 filed with the SEC on November 10, 2022 and declared effective by the SEC on November 21, 2022, and which is incorporated herein by reference."}